- Home
- RPRX vs QXO Comparison
RPRX vs QXO Comparison
Compare RPRX & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | QXO |
|---|---|---|
| Founded | 1996 | 1988 |
| Country | United States | United States |
| Employees | N/A | 211 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 16.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | QXO |
|---|---|---|
| Price | $46.15 | $20.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $47.75 | $33.17 |
| AVG Volume (30 Days) | 2.7M | ★ 5.5M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.30 | $67.94 |
| Revenue Next Year | $4.80 | $37.19 |
| P/E Ratio | $25.63 | ★ N/A |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $29.66 | $11.97 |
| 52 Week High | $47.86 | $27.61 |
Technical Indicators
Market Signals| Indicator | RPRX | QXO |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 38.84 |
| Support Level | $44.94 | $20.58 |
| Resistance Level | $46.14 | $21.97 |
| Average True Range (ATR) | 0.92 | 1.07 |
| MACD | -0.23 | -0.41 |
| Stochastic Oscillator | 39.36 | 23.91 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About QXO QXO Inc.
QXO Inc is the publicly traded distributor of roofing, waterproofing and complementary building products in the United States. The company aims to become the tech-enabled leader in the approximately $800 billion building products distribution industry and generate outsized value for shareholders. It is targeting nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.